Abcam

At abcam, abcam, we believe the scientific community goes further, faster, when we go there together. We provide abcam and scientific support to the research and clinical communities, offering highly validated reagents to address key targets in critical biological pathways.

Abcam was listed on the Nasdaq [3] and the London Stock Exchange until it was acquired by Danaher Corporation in The company was founded in by Jonathan Milner with co-founders professor Tony Kouzarides and David Cleevely , with the idea of making it easier for research scientists to buy antibodies across the web. The project had slowed because of problems finding quality antibody reagents that had honest and up-to-date information about their uses and limitations. This scenario provided the motivation to form an on-line service that would help themselves and researchers across the globe. Since its inception in , the company has diversified from carrying only antibodies. It supplies antibody related products such as immunoassays e. Abcam also has a portfolio of non-antibody related products such as biochemicals, cellular assays, and epigenetics kits e.

Abcam

Powered by. Abcam Plc Abcam is a supplier of life science research tools for analysis of living cells at molecular level to understand a wide range of disease conditions. The company develops and markets antibodies and other related products. Its product portfolio includes primary antibodies, secondary antibodies, immunoassay kits and reagents, cell and tissue imaging tools, cellular and biochemical assays, proteomics tools, proteins and peptides, activators, agonists, antagonists and inhibitors, lysates, and multiplex miRNA assay. The company distributes its products in the Americas, Europe, Asia-Pacific, and other countries. Abcam is headquartered in Cambridge, Cambridgeshire, the UK. A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included. History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events. Have you found what you were looking for? Contact the team or request a demo to find out how our data can drive your business forward.

Categories : Biotechnology companies of the United Kingdom Companies based in Cambridge Companies formerly listed on the Alternative Investment Market Biotechnology companies established in establishments in England mergers and abcam Companies formerly listed on the Nasdaq Danaher subsidiaries, abcam.

.

At abcam, we believe the scientific community goes further, faster, when we go there together. We provide tools and scientific support to the research and clinical communities, offering highly validated reagents to address key targets in critical biological pathways. By actively listening to and collaborating with the research community, we continuously advance our portfolio to address their needs. Our principal catalogue product lines include primary and secondary antibodies, conjugated antibodies and conjugation kits, and singleplex immunoassays. We also offer peptides and proteins, knockout cell lines and lysates, as well as a variety of other products including cellular activity kits, and biochemical and cell signaling pathway tools.

Abcam

We envision a world in which all life scientists have access to the precise tools and solutions they need to accurately advance their research, resulting in faster breakthroughs in scientific understanding, and an accelerated transition of those breakthroughs into clinical applications. This, we believe, will ultimately lead to improved diagnoses, treatments and human health and wellbeing. Every year around , life science researchers depend on our products and technical support. Located in over countries, our customers work in academia, research institutes, and pharmaceutical, biotechnology and diagnostics companies. Together with high performance products, we provide expert customer support and rapid delivery, enabling our customers to reach their goals and achieve their mission, faster. We are at the forefront of providing sustainable and reliable proteomic tools to the life science community. Our portfolio of off-the-shelf products and customized solutions are designed to perform consistently — first time, every time. Our award-winning validated antibodies help scientists to save time and valuable resources, ensuring reproducible results and reliable scientific insights. The need for new research tools is constant as users deepen scientific understanding and search for the next breakthrough.

The meat and wine co south yarra menu

Archived from the original on 22 August Life Sciences. Retrieved 9 May Call 44 0 Retrieved 12 August Key Parameters Abcam Plc F. Retrieved 16 September Mary Ann Liebert, Inc. On 11 November , Abcam announced the acquisition of AxioMx. History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events. Manufacturing Chemist.

Your browser does not have JavaScript enabled and some parts of this website will not work without it. For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome.

Business Insider. Search Clear. Book a demo. US Securities and Exchange Commission. Authority control databases ISNI. The acquisition of Marker Gene Technologies bring expertise in the areas of biology, organic synthesis and fluorescence chemistry. We provide tools and scientific support to the research and clinical communities, offering highly validated reagents to address key targets in critical biological pathways. About the company. Today, we help , researchers in over countries deliver faster breakthroughs in cancer, neurological disorders, infectious diseases, and metabolic disorder areas. Save hours of research time and resources with our up-to-date Abcam Plc Strategy Report Understand Abcam Plc position in the market, performance and strategic initiatives. Book consultation.